Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis [Phase 2]

View source ↗

Summary

This is a Phase 2 study to evaluate the efficacy and safety of IMG-007 in adults with moderate-to-severe atopic dermatitis, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• IMG-007

Snippet

Sponsor: Inmagene LLC | Conditions: Atopic Dermatitis, Atopic Dermatitis Eczema | Phase 2 | Status: RECRUITING